Browsing Tag
Osteoarthritis
14 posts
Zoetis (NYSE: ZTS) gains EMA panel endorsement for Lenivia — Could this reshape the €10bn companion-animal market?
Zoetis (NYSE: ZTS) earns EMA panel endorsement for Lenivia, a long-acting antibody injection for canine osteoarthritis pain. Find out what this means for investors and the veterinary industry.
Paradigm Biopharmaceuticals (ASX: PAR) hits key Phase 3 milestone as dosing begins in U.S. and Australia
Paradigm Biopharmaceuticals (ASX: PAR) begins dosing in its pivotal Phase 3 osteoarthritis trial, setting up a mid-2026 data readout that could redefine its future.
Wearing high heels and arthritis: What is the real link between fashion choices and long-term joint health?
Wearing high heels changes body posture and joint load, raising arthritis risk. Learn the science, risks, and preventive tips for long-term joint health.
Pacira BioSciences strengthens gene therapy pipeline with GQ Bio takeover
Pacira BioSciences, Inc. has taken a significant step toward expanding its presence in genetic medicine by acquiring the…
Paradigm Biopharmaceuticals scores A$16m investment—Here’s what it means for osteoarthritis treatment
Paradigm Biopharmaceuticals Ltd. (ASX: PAR) has secured a significant A$16 million in funding, positioning the company to launch…
Zydus Lifesciences’ Diclofenac Sodium and Misoprostol Tablets gets FDA final approval
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market…
Syngene signs Librela-focused biologics manufacturing agreement with Zoetis
Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing…
Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US
Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and…
Ensemble Orthopedics secures FDA clearance for innovative CMC implant for osteoarthritis treatment
Ensemble Orthopedics, a Texas-based medical device company, has secured 510(k) clearance from the US Food and Drug Administration…
Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346
Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical…